AMBI: Ambit Biosciences Corp Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) 200.10
Book Value ($M) 42.11
Book Value / Share 2.34
Price / Book 6.01
NCAV ($M) n/a
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.19
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio 4.03

Balance Sheet (mrq) ($M)
Current Assets 54.85
Assets 55.71
Liabilities 13.60
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income -7.03
Net Income -11.20

Cash Flow Statement (mra) ($M)
Cash From Operations -27.30
Cash from Investing -0.63
Cash from Financing -0.63

Source:
Fintel.io
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

Similar Companies
ALXA – Alexza Pharmaceuticals, Inc. ALXN – Alexion Pharmaceuticals, Inc.
AMAG – AMAG Pharmaceuticals, Inc. AMGN – Amgen Inc.
AMPH – Amphastar Pharmaceuticals, Inc.


Financial data and stock pages provided for FREE by
Fintel.io